9/11 and Lymphoma Links?

As if being involved in the 9/11 attack on the World Trade Centers wasn't horrific enough, it's now appearing as if people present at the WTC on that world-changing day have higher than normal rates of lymphatic and blood cancers.


While New York city's health commissioner has said there is no evidence linking dust exposure to cancer, the Medical Monitoring Program reports a "handful of cases of multiple myeloma in very young individuals." They add, "multiple myeloma is a condition that ... almost aways presents later in life."


However, because the disease may take years to develop in some individuals, proof of a correlation most likely won't emerge for decades. This is all in addition to the confirmed respiratory illnesses found in 70% of the nearly 40,000 Ground Zero workers.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap